nodes	percent_of_prediction	percent_of_DWPC	metapath
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—ZFP42—germ cell cancer	0.0825	0.265	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—SOX17—germ cell cancer	0.0452	0.145	CbGpPWpGaD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—NANOG—germ cell cancer	0.0434	0.139	CbGpPWpGaD
Plerixafor—CXCR4—endothelium—germ cell cancer	0.0428	0.111	CbGeAlD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—POU5F1—germ cell cancer	0.0417	0.134	CbGpPWpGaD
Plerixafor—CXCR4—blood vessel—germ cell cancer	0.0395	0.102	CbGeAlD
Plerixafor—CXCR4—trigeminal ganglion—germ cell cancer	0.0244	0.0631	CbGeAlD
Plerixafor—CXCR4—embryo—germ cell cancer	0.0235	0.0609	CbGeAlD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—SOX2—germ cell cancer	0.0231	0.0744	CbGpPWpGaD
Plerixafor—CXCR4—eye—germ cell cancer	0.021	0.0543	CbGeAlD
Plerixafor—CXCR4—retina—germ cell cancer	0.0208	0.0539	CbGeAlD
Plerixafor—CXCR4—telencephalon—germ cell cancer	0.0192	0.0495	CbGeAlD
Plerixafor—CXCR4—decidua—germ cell cancer	0.0182	0.047	CbGeAlD
Plerixafor—CXCR4—Hematopoietic Stem Cell Differentiation—KITLG—germ cell cancer	0.0175	0.0562	CbGpPWpGaD
Plerixafor—CXCR4—uterus—germ cell cancer	0.0159	0.0411	CbGeAlD
Plerixafor—CXCR4—pituitary gland—germ cell cancer	0.0156	0.0403	CbGeAlD
Plerixafor—CXCR4—medulla oblongata—germ cell cancer	0.015	0.0389	CbGeAlD
Plerixafor—CXCR4—adrenal gland—germ cell cancer	0.0139	0.036	CbGeAlD
Plerixafor—CXCR4—midbrain—germ cell cancer	0.0138	0.0356	CbGeAlD
Plerixafor—CXCR4—bone marrow—germ cell cancer	0.0135	0.0349	CbGeAlD
Plerixafor—CXCR4—spinal cord—germ cell cancer	0.0134	0.0347	CbGeAlD
Plerixafor—CXCR4—female gonad—germ cell cancer	0.013	0.0336	CbGeAlD
Plerixafor—Induration—Bleomycin—germ cell cancer	0.0129	0.0426	CcSEcCtD
Plerixafor—CXCR4—endocrine gland—germ cell cancer	0.0121	0.0312	CbGeAlD
Plerixafor—CXCR4—head—germ cell cancer	0.0119	0.0308	CbGeAlD
Plerixafor—CXCR4—testis—germ cell cancer	0.0115	0.0298	CbGeAlD
Plerixafor—CXCR4—cerebellum—germ cell cancer	0.0106	0.0275	CbGeAlD
Plerixafor—CXCR4—Cardiac Progenitor Differentiation—KIT—germ cell cancer	0.00952	0.0306	CbGpPWpGaD
Plerixafor—Induration—Etoposide—germ cell cancer	0.00869	0.0287	CcSEcCtD
Plerixafor—CXCR4—brain—germ cell cancer	0.00864	0.0224	CbGeAlD
Plerixafor—CXCR4—lymph node—germ cell cancer	0.00835	0.0216	CbGeAlD
Plerixafor—CXCR4—Peptide ligand-binding receptors—OXT—germ cell cancer	0.00717	0.023	CbGpPWpGaD
Plerixafor—Inflammation—Ifosfamide—germ cell cancer	0.00507	0.0168	CcSEcCtD
Plerixafor—CXCR4—Peptide ligand-binding receptors—AVP—germ cell cancer	0.00491	0.0158	CbGpPWpGaD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—OXT—germ cell cancer	0.00481	0.0155	CbGpPWpGaD
Plerixafor—Swelling—Ifosfamide—germ cell cancer	0.00405	0.0134	CcSEcCtD
Plerixafor—Inflammation—Etoposide—germ cell cancer	0.00401	0.0133	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—OXT—germ cell cancer	0.00366	0.0118	CbGpPWpGaD
Plerixafor—Haemoglobin—Vinblastine—germ cell cancer	0.00344	0.0114	CcSEcCtD
Plerixafor—Haemorrhage—Vinblastine—germ cell cancer	0.00342	0.0113	CcSEcCtD
Plerixafor—CXCR4—Class A/1 (Rhodopsin-like receptors)—AVP—germ cell cancer	0.0033	0.0106	CbGpPWpGaD
Plerixafor—Swelling—Etoposide—germ cell cancer	0.0032	0.0106	CcSEcCtD
Plerixafor—Haemoglobin—Bleomycin—germ cell cancer	0.00291	0.00961	CcSEcCtD
Plerixafor—Haemorrhage—Bleomycin—germ cell cancer	0.00289	0.00956	CcSEcCtD
Plerixafor—Orthostatic hypotension—Cisplatin—germ cell cancer	0.00281	0.0093	CcSEcCtD
Plerixafor—Ill-defined disorder—Vinblastine—germ cell cancer	0.00277	0.00914	CcSEcCtD
Plerixafor—Malaise—Vinblastine—germ cell cancer	0.00269	0.00889	CcSEcCtD
Plerixafor—Abdominal discomfort—Cisplatin—germ cell cancer	0.00255	0.00844	CcSEcCtD
Plerixafor—Erythema—Bleomycin—germ cell cancer	0.00252	0.00832	CcSEcCtD
Plerixafor—CXCR4—GPCR ligand binding—AVP—germ cell cancer	0.00251	0.00807	CbGpPWpGaD
Plerixafor—Discomfort—Vinblastine—germ cell cancer	0.00251	0.00829	CcSEcCtD
Plerixafor—Haemoglobin—Ifosfamide—germ cell cancer	0.00248	0.00821	CcSEcCtD
Plerixafor—Haemorrhage—Ifosfamide—germ cell cancer	0.00247	0.00817	CcSEcCtD
Plerixafor—Connective tissue disorder—Ifosfamide—germ cell cancer	0.00243	0.00803	CcSEcCtD
Plerixafor—Inflammation—Methotrexate—germ cell cancer	0.0024	0.00794	CcSEcCtD
Plerixafor—CXCR4—Disease—SLC2A3—germ cell cancer	0.00236	0.00757	CbGpPWpGaD
Plerixafor—Erythema—Dactinomycin—germ cell cancer	0.00235	0.00776	CcSEcCtD
Plerixafor—Ill-defined disorder—Bleomycin—germ cell cancer	0.00234	0.00772	CcSEcCtD
Plerixafor—Malaise—Bleomycin—germ cell cancer	0.00227	0.00751	CcSEcCtD
Plerixafor—Immune system disorder—Ifosfamide—germ cell cancer	0.00223	0.00738	CcSEcCtD
Plerixafor—Paraesthesia—Vinblastine—germ cell cancer	0.00218	0.00722	CcSEcCtD
Plerixafor—Ill-defined disorder—Dactinomycin—germ cell cancer	0.00218	0.0072	CcSEcCtD
Plerixafor—Mental disorder—Ifosfamide—germ cell cancer	0.00217	0.00716	CcSEcCtD
Plerixafor—Erythema—Ifosfamide—germ cell cancer	0.00215	0.00711	CcSEcCtD
Plerixafor—Discomfort—Bleomycin—germ cell cancer	0.00212	0.007	CcSEcCtD
Plerixafor—Malaise—Dactinomycin—germ cell cancer	0.00212	0.007	CcSEcCtD
Plerixafor—Connective tissue disorder—Cisplatin—germ cell cancer	0.00209	0.00692	CcSEcCtD
Plerixafor—Pain—Vinblastine—germ cell cancer	0.00208	0.00688	CcSEcCtD
Plerixafor—Constipation—Vinblastine—germ cell cancer	0.00208	0.00688	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—OXT—germ cell cancer	0.00207	0.00665	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Bleomycin—germ cell cancer	0.00205	0.00679	CcSEcCtD
Plerixafor—Feeling abnormal—Vinblastine—germ cell cancer	0.002	0.00663	CcSEcCtD
Plerixafor—Ill-defined disorder—Ifosfamide—germ cell cancer	0.002	0.0066	CcSEcCtD
Plerixafor—Gastrointestinal pain—Vinblastine—germ cell cancer	0.00199	0.00658	CcSEcCtD
Plerixafor—Discomfort—Dactinomycin—germ cell cancer	0.00197	0.00653	CcSEcCtD
Plerixafor—Malaise—Ifosfamide—germ cell cancer	0.00194	0.00642	CcSEcCtD
Plerixafor—Immune system disorder—Cisplatin—germ cell cancer	0.00192	0.00636	CcSEcCtD
Plerixafor—Abdominal pain—Vinblastine—germ cell cancer	0.00192	0.00636	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—OXT—germ cell cancer	0.00188	0.00604	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Bleomycin—germ cell cancer	0.00187	0.00619	CcSEcCtD
Plerixafor—Erythema—Cisplatin—germ cell cancer	0.00185	0.00613	CcSEcCtD
Plerixafor—Paraesthesia—Bleomycin—germ cell cancer	0.00184	0.0061	CcSEcCtD
Plerixafor—Dyspnoea—Bleomycin—germ cell cancer	0.00183	0.00606	CcSEcCtD
Plerixafor—Arthralgia—Ifosfamide—germ cell cancer	0.00183	0.00606	CcSEcCtD
Plerixafor—Flatulence—Cisplatin—germ cell cancer	0.00183	0.00604	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—germ cell cancer	0.00182	0.00602	CcSEcCtD
Plerixafor—Discomfort—Ifosfamide—germ cell cancer	0.00181	0.00598	CcSEcCtD
Plerixafor—Hypersensitivity—Vinblastine—germ cell cancer	0.00179	0.00593	CcSEcCtD
Plerixafor—Immune system disorder—Etoposide—germ cell cancer	0.00176	0.00583	CcSEcCtD
Plerixafor—Pain—Bleomycin—germ cell cancer	0.00176	0.00581	CcSEcCtD
Plerixafor—Anaphylactic shock—Ifosfamide—germ cell cancer	0.00176	0.00581	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Dactinomycin—germ cell cancer	0.00175	0.00577	CcSEcCtD
Plerixafor—Asthenia—Vinblastine—germ cell cancer	0.00175	0.00577	CcSEcCtD
Plerixafor—Nervous system disorder—Ifosfamide—germ cell cancer	0.00172	0.00569	CcSEcCtD
Plerixafor—Ill-defined disorder—Cisplatin—germ cell cancer	0.00172	0.00569	CcSEcCtD
Plerixafor—Skin disorder—Ifosfamide—germ cell cancer	0.00171	0.00564	CcSEcCtD
Plerixafor—Hyperhidrosis—Ifosfamide—germ cell cancer	0.0017	0.00561	CcSEcCtD
Plerixafor—Feeling abnormal—Bleomycin—germ cell cancer	0.00169	0.0056	CcSEcCtD
Plerixafor—Malaise—Cisplatin—germ cell cancer	0.00167	0.00553	CcSEcCtD
Plerixafor—Diarrhoea—Vinblastine—germ cell cancer	0.00166	0.0055	CcSEcCtD
Plerixafor—Fatigue—Dactinomycin—germ cell cancer	0.00165	0.00546	CcSEcCtD
Plerixafor—Pain—Dactinomycin—germ cell cancer	0.00164	0.00542	CcSEcCtD
Plerixafor—Urticaria—Bleomycin—germ cell cancer	0.00163	0.0054	CcSEcCtD
Plerixafor—Dizziness—Vinblastine—germ cell cancer	0.00161	0.00532	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Ifosfamide—germ cell cancer	0.0016	0.00529	CcSEcCtD
Plerixafor—Feeling abnormal—Dactinomycin—germ cell cancer	0.00158	0.00522	CcSEcCtD
Plerixafor—Paraesthesia—Ifosfamide—germ cell cancer	0.00158	0.00521	CcSEcCtD
Plerixafor—Ill-defined disorder—Etoposide—germ cell cancer	0.00158	0.00521	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—germ cell cancer	0.00157	0.00519	CcSEcCtD
Plerixafor—Gastrointestinal pain—Dactinomycin—germ cell cancer	0.00157	0.00518	CcSEcCtD
Plerixafor—Dyspnoea—Ifosfamide—germ cell cancer	0.00157	0.00518	CcSEcCtD
Plerixafor—Discomfort—Cisplatin—germ cell cancer	0.00156	0.00516	CcSEcCtD
Plerixafor—Vomiting—Vinblastine—germ cell cancer	0.00155	0.00511	CcSEcCtD
Plerixafor—Malaise—Etoposide—germ cell cancer	0.00153	0.00507	CcSEcCtD
Plerixafor—Headache—Vinblastine—germ cell cancer	0.00152	0.00504	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Ifosfamide—germ cell cancer	0.00152	0.00501	CcSEcCtD
Plerixafor—Abdominal pain—Dactinomycin—germ cell cancer	0.00151	0.00501	CcSEcCtD
Plerixafor—Fatigue—Ifosfamide—germ cell cancer	0.00151	0.00501	CcSEcCtD
Plerixafor—Anaphylactic shock—Cisplatin—germ cell cancer	0.00151	0.00501	CcSEcCtD
Plerixafor—Hypersensitivity—Bleomycin—germ cell cancer	0.00151	0.00501	CcSEcCtD
Plerixafor—Constipation—Ifosfamide—germ cell cancer	0.0015	0.00497	CcSEcCtD
Plerixafor—Pain—Ifosfamide—germ cell cancer	0.0015	0.00497	CcSEcCtD
Plerixafor—Loss of consciousness—Etoposide—germ cell cancer	0.00149	0.00494	CcSEcCtD
Plerixafor—Nervous system disorder—Cisplatin—germ cell cancer	0.00148	0.00491	CcSEcCtD
Plerixafor—Asthenia—Bleomycin—germ cell cancer	0.00147	0.00487	CcSEcCtD
Plerixafor—Skin disorder—Cisplatin—germ cell cancer	0.00147	0.00486	CcSEcCtD
Plerixafor—Hyperhidrosis—Cisplatin—germ cell cancer	0.00146	0.00484	CcSEcCtD
Plerixafor—Pruritus—Bleomycin—germ cell cancer	0.00145	0.00481	CcSEcCtD
Plerixafor—Feeling abnormal—Ifosfamide—germ cell cancer	0.00145	0.00478	CcSEcCtD
Plerixafor—Nausea—Vinblastine—germ cell cancer	0.00144	0.00478	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—germ cell cancer	0.00144	0.00475	CcSEcCtD
Plerixafor—Gastrointestinal pain—Ifosfamide—germ cell cancer	0.00144	0.00475	CcSEcCtD
Plerixafor—Discomfort—Etoposide—germ cell cancer	0.00143	0.00473	CcSEcCtD
Plerixafor—CXCR4—GPCR downstream signaling—AVP—germ cell cancer	0.00142	0.00456	CbGpPWpGaD
Plerixafor—Hypersensitivity—Dactinomycin—germ cell cancer	0.00141	0.00467	CcSEcCtD
Plerixafor—Abdominal discomfort—Methotrexate—germ cell cancer	0.0014	0.00463	CcSEcCtD
Plerixafor—Urticaria—Ifosfamide—germ cell cancer	0.00139	0.00461	CcSEcCtD
Plerixafor—Abdominal pain—Ifosfamide—germ cell cancer	0.00139	0.00459	CcSEcCtD
Plerixafor—Anaphylactic shock—Etoposide—germ cell cancer	0.00139	0.00459	CcSEcCtD
Plerixafor—Musculoskeletal discomfort—Cisplatin—germ cell cancer	0.00138	0.00456	CcSEcCtD
Plerixafor—Asthenia—Dactinomycin—germ cell cancer	0.00137	0.00455	CcSEcCtD
Plerixafor—Paraesthesia—Cisplatin—germ cell cancer	0.00136	0.00449	CcSEcCtD
Plerixafor—CXCR4—Disease—FGF4—germ cell cancer	0.00135	0.00435	CbGpPWpGaD
Plerixafor—Dyspnoea—Cisplatin—germ cell cancer	0.00135	0.00446	CcSEcCtD
Plerixafor—Skin disorder—Etoposide—germ cell cancer	0.00135	0.00445	CcSEcCtD
Plerixafor—Hyperhidrosis—Etoposide—germ cell cancer	0.00134	0.00443	CcSEcCtD
Plerixafor—Diarrhoea—Dactinomycin—germ cell cancer	0.00131	0.00434	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Cisplatin—germ cell cancer	0.00131	0.00432	CcSEcCtD
Plerixafor—Vomiting—Bleomycin—germ cell cancer	0.00131	0.00432	CcSEcCtD
Plerixafor—Rash—Bleomycin—germ cell cancer	0.0013	0.00428	CcSEcCtD
Plerixafor—Pain—Cisplatin—germ cell cancer	0.00129	0.00428	CcSEcCtD
Plerixafor—Dermatitis—Bleomycin—germ cell cancer	0.00129	0.00428	CcSEcCtD
Plerixafor—Hypersensitivity—Ifosfamide—germ cell cancer	0.00129	0.00428	CcSEcCtD
Plerixafor—CXCR4—Signaling by GPCR—AVP—germ cell cancer	0.00129	0.00414	CbGpPWpGaD
Plerixafor—Asthenia—Ifosfamide—germ cell cancer	0.00126	0.00417	CcSEcCtD
Plerixafor—Feeling abnormal—Cisplatin—germ cell cancer	0.00125	0.00412	CcSEcCtD
Plerixafor—Paraesthesia—Etoposide—germ cell cancer	0.00125	0.00412	CcSEcCtD
Plerixafor—Pruritus—Ifosfamide—germ cell cancer	0.00124	0.00411	CcSEcCtD
Plerixafor—Dyspnoea—Etoposide—germ cell cancer	0.00124	0.00409	CcSEcCtD
Plerixafor—Nausea—Bleomycin—germ cell cancer	0.00122	0.00404	CcSEcCtD
Plerixafor—Vomiting—Dactinomycin—germ cell cancer	0.00122	0.00403	CcSEcCtD
Plerixafor—CXCR4—Disease—H2AFZ—germ cell cancer	0.00121	0.00388	CbGpPWpGaD
Plerixafor—Rash—Dactinomycin—germ cell cancer	0.00121	0.004	CcSEcCtD
Plerixafor—Diarrhoea—Ifosfamide—germ cell cancer	0.0012	0.00397	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Etoposide—germ cell cancer	0.0012	0.00396	CcSEcCtD
Plerixafor—Fatigue—Etoposide—germ cell cancer	0.0012	0.00395	CcSEcCtD
Plerixafor—Pain—Etoposide—germ cell cancer	0.00119	0.00392	CcSEcCtD
Plerixafor—Constipation—Etoposide—germ cell cancer	0.00119	0.00392	CcSEcCtD
Plerixafor—Haemoglobin—Methotrexate—germ cell cancer	0.00118	0.00389	CcSEcCtD
Plerixafor—Haemorrhage—Methotrexate—germ cell cancer	0.00117	0.00387	CcSEcCtD
Plerixafor—Dizziness—Ifosfamide—germ cell cancer	0.00116	0.00384	CcSEcCtD
Plerixafor—Feeling abnormal—Etoposide—germ cell cancer	0.00114	0.00378	CcSEcCtD
Plerixafor—Nausea—Dactinomycin—germ cell cancer	0.00114	0.00376	CcSEcCtD
Plerixafor—Gastrointestinal pain—Etoposide—germ cell cancer	0.00113	0.00375	CcSEcCtD
Plerixafor—Vomiting—Ifosfamide—germ cell cancer	0.00112	0.00369	CcSEcCtD
Plerixafor—Hypersensitivity—Cisplatin—germ cell cancer	0.00112	0.00369	CcSEcCtD
Plerixafor—CXCR4—Disease—KITLG—germ cell cancer	0.00111	0.00357	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—OXT—germ cell cancer	0.00111	0.00357	CbGpPWpGaD
Plerixafor—Rash—Ifosfamide—germ cell cancer	0.00111	0.00366	CcSEcCtD
Plerixafor—Dermatitis—Ifosfamide—germ cell cancer	0.00111	0.00366	CcSEcCtD
Plerixafor—Urticaria—Etoposide—germ cell cancer	0.0011	0.00364	CcSEcCtD
Plerixafor—Abdominal pain—Etoposide—germ cell cancer	0.0011	0.00363	CcSEcCtD
Plerixafor—Asthenia—Cisplatin—germ cell cancer	0.00109	0.00359	CcSEcCtD
Plerixafor—Immune system disorder—Methotrexate—germ cell cancer	0.00106	0.00349	CcSEcCtD
Plerixafor—Nausea—Ifosfamide—germ cell cancer	0.00104	0.00345	CcSEcCtD
Plerixafor—Diarrhoea—Cisplatin—germ cell cancer	0.00104	0.00342	CcSEcCtD
Plerixafor—Mental disorder—Methotrexate—germ cell cancer	0.00102	0.00339	CcSEcCtD
Plerixafor—Hypersensitivity—Etoposide—germ cell cancer	0.00102	0.00338	CcSEcCtD
Plerixafor—Erythema—Methotrexate—germ cell cancer	0.00102	0.00337	CcSEcCtD
Plerixafor—Asthenia—Etoposide—germ cell cancer	0.000995	0.00329	CcSEcCtD
Plerixafor—Pruritus—Etoposide—germ cell cancer	0.000981	0.00324	CcSEcCtD
Plerixafor—Vomiting—Cisplatin—germ cell cancer	0.000962	0.00318	CcSEcCtD
Plerixafor—Rash—Cisplatin—germ cell cancer	0.000954	0.00316	CcSEcCtD
Plerixafor—Dermatitis—Cisplatin—germ cell cancer	0.000954	0.00315	CcSEcCtD
Plerixafor—Diarrhoea—Etoposide—germ cell cancer	0.000949	0.00314	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—FGF4—germ cell cancer	0.000947	0.00305	CbGpPWpGaD
Plerixafor—Ill-defined disorder—Methotrexate—germ cell cancer	0.000944	0.00312	CcSEcCtD
Plerixafor—Malaise—Methotrexate—germ cell cancer	0.000918	0.00304	CcSEcCtD
Plerixafor—Dizziness—Etoposide—germ cell cancer	0.000917	0.00303	CcSEcCtD
Plerixafor—Nausea—Cisplatin—germ cell cancer	0.000899	0.00297	CcSEcCtD
Plerixafor—Vomiting—Etoposide—germ cell cancer	0.000882	0.00292	CcSEcCtD
Plerixafor—Rash—Etoposide—germ cell cancer	0.000874	0.00289	CcSEcCtD
Plerixafor—Dermatitis—Etoposide—germ cell cancer	0.000874	0.00289	CcSEcCtD
Plerixafor—Headache—Etoposide—germ cell cancer	0.000869	0.00287	CcSEcCtD
Plerixafor—Arthralgia—Methotrexate—germ cell cancer	0.000866	0.00287	CcSEcCtD
Plerixafor—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—germ cell cancer	0.00086	0.00285	CcSEcCtD
Plerixafor—Discomfort—Methotrexate—germ cell cancer	0.000856	0.00283	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—H2AFZ—germ cell cancer	0.000846	0.00272	CbGpPWpGaD
Plerixafor—Anaphylactic shock—Methotrexate—germ cell cancer	0.000831	0.00275	CcSEcCtD
Plerixafor—CXCR4—Disease—FGFR3—germ cell cancer	0.000826	0.00266	CbGpPWpGaD
Plerixafor—Nausea—Etoposide—germ cell cancer	0.000824	0.00272	CcSEcCtD
Plerixafor—Nervous system disorder—Methotrexate—germ cell cancer	0.000815	0.00269	CcSEcCtD
Plerixafor—Skin disorder—Methotrexate—germ cell cancer	0.000807	0.00267	CcSEcCtD
Plerixafor—Hyperhidrosis—Methotrexate—germ cell cancer	0.000803	0.00266	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KITLG—germ cell cancer	0.000778	0.0025	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—AVP—germ cell cancer	0.000761	0.00245	CbGpPWpGaD
Plerixafor—CXCR4—Disease—KIT—germ cell cancer	0.000758	0.00244	CbGpPWpGaD
Plerixafor—Musculoskeletal discomfort—Methotrexate—germ cell cancer	0.000757	0.0025	CcSEcCtD
Plerixafor—Insomnia—Methotrexate—germ cell cancer	0.000751	0.00248	CcSEcCtD
Plerixafor—Paraesthesia—Methotrexate—germ cell cancer	0.000746	0.00247	CcSEcCtD
Plerixafor—Dyspnoea—Methotrexate—germ cell cancer	0.000741	0.00245	CcSEcCtD
Plerixafor—Dyspepsia—Methotrexate—germ cell cancer	0.000731	0.00242	CcSEcCtD
Plerixafor—Gastrointestinal disorder—Methotrexate—germ cell cancer	0.000717	0.00237	CcSEcCtD
Plerixafor—Fatigue—Methotrexate—germ cell cancer	0.000716	0.00237	CcSEcCtD
Plerixafor—Pain—Methotrexate—germ cell cancer	0.00071	0.00235	CcSEcCtD
Plerixafor—Feeling abnormal—Methotrexate—germ cell cancer	0.000684	0.00226	CcSEcCtD
Plerixafor—Gastrointestinal pain—Methotrexate—germ cell cancer	0.000679	0.00225	CcSEcCtD
Plerixafor—Urticaria—Methotrexate—germ cell cancer	0.00066	0.00218	CcSEcCtD
Plerixafor—Abdominal pain—Methotrexate—germ cell cancer	0.000657	0.00217	CcSEcCtD
Plerixafor—Hypersensitivity—Methotrexate—germ cell cancer	0.000612	0.00202	CcSEcCtD
Plerixafor—Asthenia—Methotrexate—germ cell cancer	0.000596	0.00197	CcSEcCtD
Plerixafor—Pruritus—Methotrexate—germ cell cancer	0.000588	0.00194	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—FGFR3—germ cell cancer	0.000578	0.00186	CbGpPWpGaD
Plerixafor—Diarrhoea—Methotrexate—germ cell cancer	0.000568	0.00188	CcSEcCtD
Plerixafor—Dizziness—Methotrexate—germ cell cancer	0.000549	0.00182	CcSEcCtD
Plerixafor—CXCR4—Signaling Pathways—KIT—germ cell cancer	0.000531	0.00171	CbGpPWpGaD
Plerixafor—Vomiting—Methotrexate—germ cell cancer	0.000528	0.00175	CcSEcCtD
Plerixafor—Rash—Methotrexate—germ cell cancer	0.000524	0.00173	CcSEcCtD
Plerixafor—Dermatitis—Methotrexate—germ cell cancer	0.000523	0.00173	CcSEcCtD
Plerixafor—Headache—Methotrexate—germ cell cancer	0.00052	0.00172	CcSEcCtD
Plerixafor—Nausea—Methotrexate—germ cell cancer	0.000493	0.00163	CcSEcCtD
Plerixafor—CXCR4—Disease—MYC—germ cell cancer	0.000417	0.00134	CbGpPWpGaD
Plerixafor—CXCR4—Signaling by GPCR—HRAS—germ cell cancer	0.000389	0.00125	CbGpPWpGaD
Plerixafor—CXCR4—Disease—HRAS—germ cell cancer	0.000328	0.00105	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—MYC—germ cell cancer	0.000292	0.000939	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—TP53—germ cell cancer	0.00024	0.000772	CbGpPWpGaD
Plerixafor—CXCR4—Signaling Pathways—HRAS—germ cell cancer	0.00023	0.000738	CbGpPWpGaD
